Q2 2025 13F Holders as of 6/30/2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
57.1M
-
Number of holders
-
275
-
Total 13F shares, excl. options
-
51.2M
-
Shares change
-
+829K
-
Total reported value, excl. options
-
$1.62B
-
Value change
-
+$22.9M
-
Put/Call ratio
-
0.22
-
Number of buys
-
165
-
Number of sells
-
-97
-
Price
-
$31.60
Significant Holders of Harmony Biosciences Holdings, Inc. - Common Stock (HRMY) as of Q2 2025
311 filings reported holding HRMY - Harmony Biosciences Holdings, Inc. - Common Stock as of Q2 2025.
Harmony Biosciences Holdings, Inc. - Common Stock (HRMY) has 275 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 51.2M shares
of 57.1M outstanding shares and own 89.71% of the company stock.
Largest 10 shareholders include BlackRock, Inc. (6.74M shares), Valor Management LLC (6.62M shares), VANGUARD GROUP INC (5.11M shares), FMR LLC (4.69M shares), STATE STREET CORP (1.63M shares), DIMENSIONAL FUND ADVISORS LP (1.58M shares), AMERICAN CENTURY COMPANIES INC (1.5M shares), LSV ASSET MANAGEMENT (1.49M shares), MARSHALL WACE, LLP (1.21M shares), and GEODE CAPITAL MANAGEMENT, LLC (1.05M shares).
This table shows the top 275 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.